Ant venom allergy treatment: does it last?
NCT ID NCT06935890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well venom immunotherapy protects people with Jack Jumper ant allergy years after treatment stops. About 100 adults who completed 3-6 years of therapy and have been off treatment for at least 18 months will have a supervised sting challenge and blood test. Researchers will also track field stings and quality of life to see if the protection lasts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Monash Medical Centre
RECRUITINGClayton, Victoria, 3168, Australia
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Royal Hobart Hospital
RECRUITINGHobart, Tasmania, 7000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI coach and simple exercises help cancer patients fight frailty?
- Triple therapy takes on rare, aggressive kidney cancer
- Bladder cancer drug delivered directly: a new hope for BCG failures
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Immunotherapy combo may boost rectal cancer treatment
- New cocktail aims to make immunotherapy work for common colorectal cancer